# Oramed Pharmaceuticals Inc.: Form 8-K, filed Mar 3, 2025

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2025-03-03
- Accepted by EDGAR: Mar 3, 2025, 21:30 ET
- Period: 2025-02-28
- Accession: 0001213900-25-019437
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025019437/ea0232721-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390025019437/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390025019437/ea0232721-8k_oramed.htm

Filed Mar 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-019437. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.